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In Escherichia coli, the SecYEG complex mediates the
translocation and membrane integration of proteins.
Both genetic and biochemical data indicate interactions
of several transmembrane segments (TMSs) of SecY with
SecE. By means of cysteine scanning mutagenesis, we
have identified intermolecular sites of contact between
TMS7 of SecY and TMS3 of SecE. The cross-linking of
SecY to SecE demonstrates that these subunits are pres-
ent in a one-to-one stoichiometry within the SecYEG
complex. Sites in TMS3 of SecE involved in SecE dimer-
ization are confined to a specific -helical interface and
occur in an oligomeric SecYEG complex. Although cross-
linking reversibly inactivates translocation, the contact
between TMS7 of SecY and TMS3 of SecE remains unal-
tered upon insertion of the preprotein into the translo-
cation channel. These data support a model for an
oligomeric translocation channel in which pairs of
SecYEG complexes contact each other via SecE.
In bacteria, protein translocation and membrane protein
insertion is mediated by the translocase. Translocase consists
of the SecYEG membrane protein complex, and the peripher-
ally membrane-associated SecA dimer (for review, see Ref. 1).
SecA is an ATP-dependent motor protein that drives the step-
wise translocation of the precursor protein (preprotein) across
the membrane by cycles of ATP binding and hydrolysis (2–4).
SecY, SecE, and SecG are integral membrane proteins that
together form a heterotrimeric complex (5, 6) that constitutes a
high affinity binding site for SecA (7). Recent electron micro-
scopic and biochemical studies indicate that the protein con-
ducting channel is composed of a SecYEG tetramer that is
assembled by SecA from mono- and dimeric SecYEG subcom-
plexes (8).
The SecYEG complex is a member of a highly conserved
protein translocation pathway (9). It is homologous to the eu-
karyotic Sec61p complex, which consists of three subunits, , ,
and , that together form the “translocon” of the endoplasmic
reticulum membrane (10). SecY and SecE are essential sub-
units of the translocase. SecY comprises 10 transmembrane
segments (TMSs)1 (Fig. 1), whereas SecE is a small membrane
protein that in most bacteria contains only a single TMS. In
Escherichia coli, SecE contains three TMSs, but only the con-
served C-terminal portion including the third TMS is required
for activity (11) (Fig. 1). SecY and SecE form a stable complex
in the membrane that does not dissociate in vivo (12). In the
absence of SecE, SecY is degraded by FtsH (13). Mutations
located in the cytoplasmic loop 4 (C4) of SecY (14) and C2 and
TMS3 of SecE (15) destabilize the SecY-SecE interaction. Many
of the so-called prl mutations (protein localization) that sup-
press defects in the signal sequence are present in the secY and
secE genes. Specific combinations of these mutations in SecY
(prlA) and SecE (prlG) result in synthetic lethality, and it has
been suggested that this signifies sites of interaction between
SecY and SecE (16, 17). According to this hypothesis, the
periplasmic loop 1 (P1) of SecY and P2 of SecE are interacting
regions, whereas TMS3 of SecE interacts with TMS7 and
TMS10 of SecY. Recent studies employing cysteine mutagene-
sis indeed demonstrated that P1 of SecY and P2 of SecE (18),
and TMS2 of SecY and TMS3 of SecE (19), are in close prox-
imity. Most of the conserved residues and prlA mutations are
clustered in TMSs 2, 7, and 10 of SecY, and together with TMS3
of SecE, they form the conserved core of the SecYE complex.
Strikingly, the regions suggested to interact overlap with the
regions that have been implicated in the binding of the signal
sequence of the preprotein. TMS2 and TMS7 of Sec61, the
yeast homologue of SecY can be cross-linked to the signal
sequence of a preprotein (20). Cysteine scanning mutagenesis
also showed an interaction between two neighboring SecE mol-
ecules that is modulated by the SecA and ATP-dependent ini-
tiation of preprotein translocation (19). This observation lends
further support for an oligomeric nature of the integral mem-
brane domain of the translocase.
A central question is how the SecYEG complex forms the
protein-conducting channel. Therefore, detailed information is
required about the molecular architecture of the SecYEG com-
plex. For this purpose, we have initiated a cysteine scanning
mutagenesis approach to probe sites of interaction between
SecY and SecE (19). The method can also be used to detect
dynamic changes in subunit interactions. To allow the forma-
tion of a disulfide bond, the -carbons of the two cysteines need
to be in close proximity, i.e. 3–4 Å (21). We have now extended
our studies to demonstrate that TMS3 of SecE forms an -helix,
with one face that stably interacts with TMS2 and TMS7 of
SecY, whereas the opposite face dynamically interacts with
TMS3 of a neighboring SecE molecule that is part of a separate
SecYEG complex.
EXPERIMENTAL PROCEDURES
Materials—SecA (22), SecB (23), and proOmpA (24) were purified as
described. A stock solution of 80 mM Cu2(phenantroline)3 was pre-
pared as described previously (19).
Plasmids—The plasmids used to overproduce SecYEG are listed in
Table I. All mutations were introduced by a two-step polymerase chain
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reaction using a template plasmid that allows overexpression of a
cysteine-less SecYEG with an N-terminal His6-tag on SecY (19).
Cysteine mutagenesis was accompanied by the introduction of silent
modifications in restriction sites to facilitate the screening for correct
mutants. Single cysteine mutations in TMS7 of SecY were introduced
together with a BspEI site in SecY (25). The introduction of single and
double cysteine mutations in TMS3 of SecE was accompanied by the
deletion of a ClaI site between SecY and SecE (19). All mutations were
confirmed by complete sequence analysis.
Bacterial Strains, Growth Conditions, and Membrane Isolation—
Cell growth and isolation of inner membrane vesicles (IMVs) was per-
formed as described previously (19).
Cross-linking—For assays of disulfide bridge formation, IMVs (1
mg/ml) were incubated for 30 min at 37 °C in the presence of 1 mM
Cu2(phenantroline)3 (oxidized) or, as a control, with 5 mM dithiothre-
itol (DTT) (reduced). The oxidation reaction was quenched by the addi-
tion of 25 mM neocuproine (Sigma). Oxidized samples were “re-reduced”
by the incubation in 100 mM of DTT for 1 h at 37 °C. Samples were
analyzed by 12% SDS-PAGE and stained with Coomassie Brilliant Blue
or further analyzed by Western blotting onto polyvinylidene difluoride
membranes (Amersham Pharmacia Biotech) and immunostaining us-
ing antibodies against His-tagged SecY or SecE (26).
Miscellaneous Methods—Translocation reactions were performed as
described before (19). Translocation ATPase of urea-treated IMVs was
measured with proOmpA as substrate (27). Protein concentrations were
determined by the method of Lowry et al. (28) in the presence of SDS
using bovine serum albumin as a standard.
RESULTS
Construction, Expression, and Activity of Single-cysteine Mu-
tants of SecE and SecY—Previously, we have described eight
unique cysteine mutations that were introduced in TMS7 of
SecY (Val-274 to Ser-281), covering at least two turns of the
putative -helical structure (25) (Table I). Sequence alignment
and hydrophobicity analysis of the family of bacterial SecY
proteins predicts the mutations in TMS7 of SecY to be located
near the cytosolic membrane interface (Fig. 1). To investigate
possible contacts between TMS3 of SecE and TMS7 of SecY, a
new set of five unique cysteine mutations was made in TMS3 of
SecE, covering positions Leu-95 to Ala-99 (Table I). These are
predicted to be at the same membrane depth as the mutants in
TMS7 of SecY (Fig. 1). The five cysteine mutations, together
with mutation G110C in SecE, located close to the periplasmic
membrane interface, were also used to further explore the
contact interface with a neighboring TMS3 of SecE.
The single-cysteine SecE mutants were placed into a cys-
teine-less SecYEG expression vector (19) and overproduced in
E. coli strain SF100. IMVs derived from these cells were
analyzed for the SecY and SecE expression levels, SecA trans-
location ATPase activity, and proOmpA translocation. The
expression levels of the various mutants as analyzed by SDS-
PAGE and Coomassie Brilliant Blue staining were found to be
identical to that of the overexpressed cysteine-less and wild-
type SecYEG complex (data not shown). The proOmpA-stimu-
lated SecA ATPase activity and the translocation of 125I-labeled
proOmpA of the mutants were indistinguishable from that of
the cysteine-less and wild-type SecYEG complex (data not
shown). None of the mutants was capable of translocating the
proOmpA variant 8-proOmpA (data not shown), which carri-
ers a defective signal sequence due to the deletion of Ile-8 (29).
This substrate is effectively translocated by PrlA4 IMVs (30).
Taken together, the data demonstrate that the introduction of
the cysteines in respective positions of TMS3 of SecE does not
alter the activity or specificity of the SecYEG complex.
SecE TMS3 Contacts a Neighboring SecE TMS3 at an -Hel-
ical Interface—To investigate the contact interface between
two TMS3 of SecE, IMVs containing overexpressed SecYEG
complex harboring unique cysteine mutations in TMS3 of SecE
(L95C, I96C, V97C, A98C, A99C, and G110C) were oxidized
with Cu2(phenantroline)3 and analyzed by SDS-PAGE and
immunodetection using an antibody against SecE (Fig. 2A).
Oxidation of the SecYE(A99C)G and SecYE(G110C)G com-
TABLE I
Plasmids
A synthetic secYEG operon behind the IPTG trc promotor was used for the plasmid-derived overexpression of the SecYEG complex. All listed
plasmids were constructed via polymerase chain reaction mutagenesis, resulting in the indicated mutations. Double and triple cysteine mutants:
the names are combined, e.g. pET2502/613 contains SecE V97C and SecY P276C mutations.
Plasmid Relevant characteristic Mutation Source
pET324 ptrc99A with LacZ in frame Ref. 26
pET607 Cysteine-less SecYEG in pET610 C329S (TGT3AGT);
C385S (TGC3AGC)
Ref. 19
SecY TMS7 mutants in pET607
pET611 V274C V274C (GTA3TGT)a Ref. 25
pET612 I275C I275C (ATC3TGC)a Ref. 25
pET613 P276C P276C (CCG3TGT)a Ref. 25
pET614 A277C A277C (GCA3TGT)a Ref. 25
pET615 I278C I278C (ATC3TGC)a Ref. 25
pET616 F279C F279C (TTC3TGC)a Ref. 25
pET617 A280C A280C (GCT3TGT)a Ref. 25
pET618 S281C S281C (TCC3TGC)a Ref. 25
pET2520 S282C S282C (AGT3TGT)a This work
SecE TMS3 mutants in pET607
pET627 L106C L106C (CTG3TGT)b Ref. 19
pET628 I107C I107C (ATC3TGC)b Ref. 19
pET2500 L95C L95C (CTG3TGT)b This work
pET2501 I96C I96C (ATT3TGT)b This work
pET2502 V97C V97C (GTG3TGT)b This work
pET2503 A98C A98C (GCT3TGT)b This work
pET2504 A99C A99C (GCG3TGT)b This work
pET2505 G110C G110C (GGA3TGT)b This work
pET2521 V100C V100C (GTT3TGT)b This work
pET2522 T101C T101C (ACC3TGC)b This work
pET2531 V97C/A99C V97C (GTG3TGT);
A99C (GCG3TGT)b
This work
pET2533 V97C/L106C V97C (GTG3TGT);
L106C (CTG3TGT)b
This work
a secY gene with BspEI (TCCGGT3TCCGGA).
b secE gene with ClaI (ATCGAT3ATCGAC).
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plexes gave rise to a pronounced 28-kDa cross-linking product
that is identical to the previously identified SecE-SecE cross-
link found for the SecYE(L106C)G complex (19). The other
single-cysteine SecE mutants did not yield a SecE-SecE cross-
link. Modeling of the TMS3 of SecE as an -helix structure
shows that Ala-99, Leu-106, and Gly-110 are confined to the
same face of the putative -helix (Fig. 7). This result confirms
the predicted -helix structure of TMS3 of SecE and demon-
strates that the interaction between neighboring SecE mole-
cules is confined to a specific side of the -helix.
To exclude the possibility that the formation of the SecE
dimers was induced by the high concentration of SecYEG upon
overexpression, the oxidation assay was repeated with IMVs
containing low amounts of SecYE(L106C)G. A low level of
SecYE(L106C)G production was achieved by growing cells har-
boring plasmid pET627 in the presence of 0.5% glucose and
omitting IPTG to prevent induction of the trc promotor activity.
Western blotting of dilution series showed no more than a
2–3-fold increase in the amount of SecE (see also Fig. 2B) and
SecY (data not shown) as compared with the endogenous level.
Overexpression upon induction by IPTG resulted in at least
250-fold increase in the SecYEG level (data not shown, and see
Fig. 2B). Samples of IMVs derived from cells harboring pET324
(empty control vector) and pET627 (SecYE(L106)G) with or
without induction of overexpression by IPTG were analyzed
after oxidation by SDS-PAGE and immunodetection using an
antibody against His-tagged SecE (Fig. 2B). Oxidation of IMVs
harboring low amounts of SecYE(L106C)G resulted in the effi-
cient cross-linking of the SecE dimer (Fig. 2B). This demon-
strates that the formation of this complex also occurs at levels
of SecYEG that are comparable to those found in wild-type
membranes.
SecE TMS3 Contacts SecY TMS7—To identify further con-
tacts between SecE and SecY, the single-cysteine mutations in
SecE TMS3 (L95C, I96C, V97C, A98C, A99C) and SecY TMS7
(V274C, I275C, P276C, A277C, I278C, F279C, A280C, and
S281C) were co-expressed yielding 40 pairs of cysteine mu-
tants. The activity of the SecY TMS7 mutants have been ana-
lyzed previously, and all mutants behave normally except for
SecY(I278C)EG that exhibits a prlA phenotype (25). All pairs
of cysteine mutants showed normal levels of overexpression
(Fig. 3A; data not shown). IMVs were oxidized with
Cu2(phenantroline)3 and analyzed by SDS-PAGE and Coo-
massie Brilliant Blue staining (Fig. 3A) or immunoblotting
using antibodies against SecY and SecE (Fig. 3B; data not
shown). For two double-cysteine combinations, a higher molec-
ular mass band was observed upon oxidation at the position of
an expected SecY-SecE cross-link. The formation of the
cross-link product of SecY(P276C) and SecE(V97C) was very
efficient, resulting in a nearly complete disappearance of mo-
nomeric SecY and SecE. This result implies a stoichiometric
interaction between SecE and SecY that was previously as-
sumed but not demonstrated experimentally. Cross-linking be-
tween SecY(P276C) and E(L95C) was less efficient. Modeling
shows that both contacts cannot be confined to the same -hel-
ical face between the corresponding transmembrane segments
(Fig. 7A).
SecY TMS7 and SecE TMS3 Contact Interface Is -Heli-
FIG. 1. Membrane topology model
of the E. coli SecY and SecE. The gray
diamonds represent the cysteine residues
present in the wild-type SecY that were
replaced by serine residues. The residues
that were replaced by cysteine are indi-
cated in black circles.
FIG. 2. Mapping of the SecE-SecE contact interface. A, IMVs
containing overproduced amounts of SecYEG with the indicated single-
cysteine mutation in TMS3 of SecE were oxidized with 1 mM
Cu2(phenantroline)3. Cysteine-less SecYEG and SecYE(I107C)G were
included as a negative control, and SecYE(L106C)G was included as a
positive control. B, IMVs were prepared from cells harboring pET324
(empty control plasmid) or pET627 (SecYE(L106C)G) grown in the
presence of 0.5% glucose to suppress expression of the SecYEG complex.
Samples were reduced (5 mM DTT) (–) or oxidized (1 mM
Cu2(phenantroline)3 (Cu
2(phe)3)) (). As a control, a 25-fold diluted
sample is shown that contained IMVs from cells induced for the over-
expression of SecYE(L106C)G complex by IPTG. All samples were an-
alyzed by 12% SDS-PAGE followed by immunoblotting using antibodies
against SecE (A) or His-tagged SecE (B). The SecE monomer (E) and
dimer (E-E) (28 kDa) are indicated by arrowheads.
SecY-SecE Interaction 32561
 at University of G
roningen on M









cal—To further investigate the structure of the interface be-
tween SecY TMS7 and SecE TMS3, additional double-cysteine
combinations were constructed of residues that are located
deeper in the membrane. Four SecY TMS7 cysteine mutations
(F279C, A280C, S281C, and S282C) were combined with two
additional SecE TMS3 cysteine mutations (V100C and T101C).
The respective SecYEG complexes again exhibit normal over-
expression levels and translocation activities (data not shown).
Upon the oxidation of the pairs of cysteine mutants, two
additional SecY-SecE cross-links could be identified after
SDS-PAGE and immunoblotting using antibodies against
SecY and SecE (Fig. 3B). These cross-links occurred between
SecY(A280C) and SecE(V100C) or SecE(T101C), but the effi-
ciency was less as compared with the SecY(P276C)-SecE(V97C)
combination. Modeling of TMS7 of SecY and TMS3 of SecE as
-helical segments shows that these newly identified contacts
are confined to the same helical interface as the SecY(P276C)-
SecE(V97C) cross-link (Fig. 7). Because the cross-link between
SecY(P276C) and SecE(L95C) cannot be modeled into this
-helical interface, we assume that SecE Leu-95 is located
outside the membranous environment in a non--helical struc-
ture (Fig. 7B).
Interaction between SecY and SecE within an Oligomeric
SecYEG Complex—Because the SecY(P276C)-SecE(V97C) and
intermolecular SecE(L106C) cross-links are very strong, a tri-
ple-cysteine mutant of the SecYEG complex was constructed to
determine whether such contacts occur within an oligomeric
SecYEG complex. IMVs prepared from cells expressing the
SecY(P276C)E(V97C/L106C)G showed normal levels of
overproduction (data not shown) and activity (Fig. 5). Immu-
nodetection of oxidized samples showed the presence of strong
SecY-(SecE)2 and weaker (SecY)2-(SecE)2 cross-link products
(Fig. 4). Similar but less efficient cross-link products could be
demonstrated for a SecY(P276C)E(V97C/A99C)G mutant (data
not shown). These data therefore suggest that the identified
SecE-SecE cross-links are at a contact interface between two
separate SecYEG complexes. In all samples, a band was ob-
served that stains with the antibody against SecE at the posi-
tion of SecY-(SecE)2 (Fig. 4). However, this band is unrelated to
these proteins, as it was also present in the reduced samples
and it did not stain with the antibody against SecY. Further-
more, in all samples, a diffuse protein band was detected that
stains with the SecY antibody and that migrates with a molec-
ular mass that is between that of the SecY-(SecE)2 and (SecY)2-
(SecE)2 cross-linking products (Fig. 4). Because this band was
observed also with the cysteine-less SecYEG complex, albeit
weaker, we assume that it represents an aggregated SecY
dimer, the formation of which is stimulated by the oxidation.
SecY-SecE and SecE-SecE Cross-linking Reversibly Inacti-
vate the Translocase—IMVs harboring overexpressed cysteine-
less SecYEG, SecYE(L106C)G, SecY(P276C)E(V97C)G, and
SecY(P276C)E(V97C/L106C)G were assayed for the effect of
cross-linking on the translocation activity. IMVs were either
reduced in the presence of DTT or oxidized with
Cu2(phenantroline)3. Oxidized samples were re-reduced by
the incubation in DTT, and the activity was assayed by the
translocation of 125I-proOmpA (Fig. 5). The activity of the cys-
teine-less SecYEG was not affected by the oxidation-reduction
conditions. Under oxidizing conditions, however, translocation
of proOmpA proceeded only to the I29 intermediate due to the
presence of a disulfide bond in the C-terminal end of proOmpA
(19). All three cysteine mutant SecYEG complexes displayed
normal activity under reduced condition but were nearly com-
pletely inactive under oxidizing conditions. With all mutants,
substantial activity could be recovered after re-reduction of the
samples.
The Interhelical SecY TMS7-SecE TMS3 Contact Is Re-
tained during Translocation—Using the thiol-mediated con-
tact between neighboring SecE molecules as a molecular
ruler, we have shown previously that during the initiation of
preprotein translocation, the intermolecular SecE contact is
enhanced (19). To investigate the dynamics of the SecY-SecE
contact, the same technique was employed using the
SecY(P276C)E(V97C)G complex. IMVs were preincubated in
DTT, incubated under various translocation conditions, and
subsequently oxidized with Cu2(phenantroline)3 to probe for
the efficiency of SecY-SecE cross-linking. Because formation of
the SecY-SecE contact is already very efficient under nontrans-
locating conditions, a less-than-optimal condition of oxidation
(on ice) was applied to be able to detect changes in the cross-
FIG. 3. Mapping of the contact in-
terface between TMS7 of SecY and
TMS3 of SecE. A, eight consecutive
unique cysteine mutations in TMS7 of
SecY (V274C, I275C, P276C, A277C,
I278C, F279C, A280C, and S281C) were
co-expressed with five cysteine mutations
in TMS3 of SecE (L95C, I96C, V97C,
A98C, and A99C) and SecG. IMVs con-
taining the mutant SecYEG complexes
were oxidized with 1 mM Cu2(phen-
antroline)3 and analyzed by 12% SDS-
PAGE and Coomassie Brilliant Blue
staining. The disulfide cross-linked SecY-
SecE complexes (50 kDa) are indicated on
the gel by an asterisk. WT, wild-type. B,
four consecutive unique cysteine muta-
tions in TMS7 of SecY (F279C, A280C,
S281C, and S282C) were co-expressed
with two cysteine mutations in TMS3 of
SecE (V100C and T101C) and SecG.
Cross-links were identified as described
above, and analyzed by SDS-PAGE and
immunoblotting using antibodies against
His-tagged SecY and SecE. The cross-link
between SecY(P276C) and SecE(V97C)
was included as a control. SecY (Y) and
SecY-SecE cross-link (Y-E) (50 kDa) are
indicated by arrowheads.
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linking efficiency. Translocation conditions were induced by
the addition of SecA and the preprotein proOmpA in the pres-
ence of ATP, AMP-PNP, or ATP in the presence of the SecA
ATPase inhibitor azide (31). None of these conditions, however,
resulted in a significant change in the efficiency of the SecY-
SecE cross-linking (Fig. 6). Therefore, it is concluded that
TMS7 of SecY and TMS3 of SecE remain in close proximity
during protein translocation.
DISCUSSION
Cysteine scanning mutagenesis is a technique that can be
used to map the sites of contacts between the helices in mem-
brane proteins. We have used this technique to obtain more
detailed information about the interaction of the two essential
components SecY and SecE of the protein-conducting channel
of E. coli. This study provides experimental evidence that
TMS3 of SecE forms an -helix with one face contacting a
neighboring SecE molecule, whereas the other face contacts
TMS7 (this study) and TMS2 (19) of SecY.
Previously, we have identified position Leu-106 of TMS3 of
SecE as a site of contact with a neighboring SecE molecule (19).
In that study, five unique cysteine substitutions were intro-
duced near the periplasmic membrane interface of TMS3 of
SecE (S105C–W109C) in order to cover a complete turn of an
-helix. To determine whether this contact interface extends
along the entire putative -helical structure, six additional
cysteine mutants were made close to the cytosolic (L95C–
A99C) and periplasmic (G110C) membrane interface. In this
screen, we now have identified two additional amino acid res-
idues in TMS3 of SecE that map at the interface between two
SecE molecules, i.e. Ala-99 and Gly-110. Modeling of TMS3 of
SecE as an -helical structure demonstrates that these resi-
dues are strictly confined to a specific side of the -helix (Fig.
7). Interestingly, the cross-linking efficiency for the L106C
mutation is significantly higher than for A99C and G110C.
This could mean that the two contacting transmembrane seg-
ments are tilted or twisted relative to each other, with an
optimal point of contact around Leu-106.
By combining a set of single cysteine mutants in TMS7 of
SecY (V274C–S282C) (25) with mutants in TMS3 of SecE
(L95C–T101C), several sites of contact between SecY and SecE
could be detected. In particular, SecY(P276C) to SecE(V97C)
could be efficiently cross-linked (Figs. 3 and 4). The same
position of SecY also cross-linked to SecE(L95C), albeit with
low efficiency (Fig. 3A). SecY(A280C) was found to contact both
SecE(V100C) and SecE(T101C) (Fig. 4). The identified sites of
contact fit with an -helical contact interface, except for the
SecY(P276C)-SecE(L95C) interaction (Fig. 7). Considering the
low efficiency of cross-linking of the latter cysteine pair, and
the uncertainty in predicting the borders of the TMSs, it seems
likely that Leu-95 of SecE is located outside the membrane
plane and is not part of the -helical structure of TMS 3. This
is illustrated in Fig. 7B.
The cross-linking of SecY(P276C) with SecE(V97C) was
nearly complete, leaving little nonreacted monomeric SecY and
SecE upon oxidation. This implies that there is only one SecE
molecule per SecY subunit in the SecYEG complex. In this
respect, their interdependent stability (12, 13), similar levels of
overexpression (32), and well defined regions of interaction (14,
FIG. 4. Disulfide cross-linking of a
SecYE dimer. IMVs containing the cys-
teine-less SecYEG, SecYE(L106C)G,
SecY(P276C)E(V97C)G, and SecY(P276C-
)E(V97C/L106C)G were reduced with 5
mM DTT (–) or oxidized with 1 mM
Cu2(phenantroline)3 (Cu
2(phe)3) ().
Samples were analyzed by 12% SDS-
PAGE and immunostaining using anti-
bodies against His-tagged SecY and SecE.
The SecE-SecE (E-E), SecY-SecE (Y-E),
SecY-(SecE)2 (Y-E2), and (SecY)2-(SecE)2
(Y2-E2) cross-links are indicated with
arrowheads.
FIG. 5. Disulfide cross-linking of the SecYEG complex reversibly inactivates proOmpA translocation. IMVs containing the cysteine-
less SecYEG, SecYE(L106C)G, SecY(P276C)E(V97C)G and SecY(P276C)E(V97C/L106C)G were reduced with 5 mM DTT (RED) or oxidized with 1
mM Cu2(phenantroline)3 (OX). A sample of the oxidized samples was re-reduced by incubation in 100 mM DTT (reRED). IMVs were supplemented
with SecA and assayed for the translocation of 125I-proOmpA as described under “Experimental Procedures.” The positions of proOmpA, OmpA,
and the translocation intermediate I29 are indicated.
SecY-SecE Interaction 32563
 at University of G
roningen on M









17–19) are consistent with the experimentally determined
SecY-SecE stoichiometry.
The cysteine scanning mutagenesis (Ref. 19 and this study)
now provides a detailed image of the molecular environment of
SecE TMS3 (Fig. 7). Herein, TMS3 of SecE is surrounded by
another TMS3 of SecE and TMS2 and TMS7 of SecY. In the
current arrangement, there is ample space for at least one
other SecE contacting helix. Based on the predictions made
FIG. 6. The interaction between TMS7 of SecY and TMS3 of SecE is not modulated during preprotein translocation. IMVs containing
the SecY(P276C)E(V97C)G complex were prereduced with 5 mM DTT and diluted into translocation mixtures (50 l) containing 50 mM
HEPES-KOH, pH 7.5, 30 mM KCl, 5 mM Mg(Ac)2. The reaction mixture was supplemented with 1 g of proOmpA, 1 g of SecA, 2 mM ATP or
AMP-PNP, and 20 mM sodium azide (NaN3) as indicated. After 10 min of incubation at 37 °C, 1 mM Cu
2(phenantroline)3 was added, and the
incubation was continued on ice for 30 min. Oxidation was terminated by the addition of 25 mM neocuproine, and the samples were analyzed by
12% SDS-PAGE and immunostaining using antibodies against His-tagged SecY or SecE (data not shown). The positions of SecY and the SecY-SecE
cross-link are indicated with arrowheads.
FIG. 7. Schematic representation
showing the identified sites of inter-
action between TMS2 and TMS7 of
SecY and TMS3 of SecE, and the iden-
tified sites of interaction between
TMS3 of neighboring SecE molecules.
A, top view. TMSs are schematically
drawn as helices. Cysteine-substituted
residues involved in the cross-linking are
shown (closed circles) and connected by a
line to the interacting amino acid resi-
dues. Sites of prlA mutations are depicted
as open circles. B, side view. Interacting
cysteine-substituted residues are indi-
cated in black boxes, and sites of known
prlA mutations are depicted in thicker
outlined boxes. The sites of interaction are
shown by connecting lines. The weak
cross-link between Leu-95 of SecE and
Pro-276 of SecY is indicated by a dotted
line.
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using the synthetic lethality of combinations of prlA and prlG
mutants (17), TMS 10 of SecY seems a likely candidate. It is of
interest to note that the amino acid residue positions that
cause the synthetic lethality of prlA208 (SecY TMS7, I278N)
with prlG1 (SecE TMS3, L108R) do not map at the SecY TMS7-
SecE TMS3 contact interface (Fig. 7). The same holds true for
all of the prlA mutations that map in TMS2 and TMS7 of SecY.
None of these amino acid residues face TMS3 of SecE, but
instead they point in the opposite direction (Fig. 7). Strikingly,
these mutations lead to a destabilization of the SecY-SecE
interaction (33), in particular when PrlA and PrlG mutants are
combined (17).
Biochemical and electron microscopic studies (8, 34) suggest
that the SecYEG complex oligomerizes to form a protein con-
ducting channel. The structure consists of a tetrameric SecYEG
complex with an outer diameter of 10.5–12 nm and a central
pore-like opening (8). The shape of the tetrameric SecYEG
complex resembles that of the ribosome-bound purified eukary-
otic Sec61p complex visualized by cryo-electron microscopy,
which is a ring-like structure 5–6 nm high and9 nm wide (35,
36). The cylindrical pore of 2 nm in diameter extends
throughout the protein complex perpendicular to the plane of
the membrane, and aligns with the protein exit tunnel of the
ribosome (35). A recent chemical cross-linking and immunopre-
cipitation study failed to demonstrate an oligomeric SecYEG
complex, and it was suggested that the SecYEG complex func-
tions as a monomer (37). It was argued that the formation of an
oligomeric SecYEG complex is an artifact of high overproduc-
tion levels and purified proteins. Our specific cysteine-mu-
tagenesis assay demonstrates that the oligomeric SecYEG
complex can also be formed at SecYEG levels comparable to
that of wild-type. Yahr and Wickner (37) used the nonspecific
cross-linker formaldehyde in their study. SecY is, however,
very unstable in the presence of low concentrations of organic
solvents, such as ethanol and formaldehyde, and it readily
denatures. This may explain the failure to detect SecY-SecY
and SecY-SecA cross-links (38). Interestingly, a recent paper on
the projection structure of the SecYEG complex indicates that
the molecule is arranged as a dimer in the crystal lattice (39).
Moreover, the same study shows by analytical ultracentrifuga-
tion, a monomer-dimer-tetramer equilibrium of the SecYEG
complex. Also, by blue native PAGE, the presence of oligomeric
SecYEG complexes is evident.2 Taken together, these studies
strongly suggest that the SecYEG complex is able to assemble
into oligomeric structures.
We have combined the strong SecY(P276C)-SecE(V97C) and
SecE(L106C)-SecE(L106C) contacts by means of a triple-cys-
teine mutant. Oxidation of the SecY(P276C)SecE(V97C/
L106C)G complex clearly demonstrates the formation of prod-
ucts that correspond to SecY-(SecE)2 and (SecY)2-(SecE)2 cross-
links. This unequivocally demonstrates that the SecE-SecE
interaction takes place at a contact interface between two
neighboring SecYEG complexes. Another cysteine scanning
mutagenesis study demonstrates that two SecG molecules are
in close proximity (40). It should be stressed that disulfide
cross-linking is a very sensitive technique that detects sites of
interaction only when they are in close proximity, i.e. within a
distance of 3–4 Å (21). Taken together, these data collaborate
with the electron microscopy studies that demonstrate that the
SecYEG complex can oligomerize into a large complex (8).
The formation of thiol-stabilized SecY-SecE and SecE-SecE
contacts reversibly inactivates the activity of the translocase
(Fig. 5) (19). Apparently, flexibility within and between
SecYEG complexes is an essential requirement for the trans-
location mechanism. This may signify conformational changes
or dynamic subunit interactions during the translocation reac-
tion, as previously shown for the SecE-SecE contact (19). By
blocking SecA membrane de-insertion, a significant enhance-
ment of the SecE-SecE cross-linking efficiency was observed.
This phenomenon strictly required the presence of a preprotein
showing its relation to the translocation process. On the other
hand, the same conditions do not result in an alteration of the
SecY-SecE cross-linking as shown for the interaction between
SecE TMS3 with SecY TMS2 (19) and SecY TMS7 (Fig. 6). A
cross-linking study with the yeast Sec61, a SecY homolog,
demonstrates the signal sequence of an inserting preprotein
contacts TMS7 and TMS2, whereas no contact could be de-
tected with Sec61 (20). This has led to the hypothesis that
Sec61 (i.e. TMS3 of SecE) might function as a kind of mock
signal sequence that is displaced from Sec61 (i.e. SecY) upon
the insertion of the signal sequence of a preprotein (20). This
mechanism is not plausible for the SecYEG complex as the
interaction between TMS2 and TMS7 of SecY with TMS3 of
SecE stably persists during translocation. It seems more likely
that the signal sequence contacts the helical faces of TMS2 and
TMS7 that point away from TMS3 of SecE. Remarkably, these
faces correspond to the sites of the PrlA mutations (Fig. 7).
The hypothesis that SecYEG functions as monomer (37) re-
quires a large rearrangement of the SecYEG helices in order to
open a translocation pore that can accommodate the inserting
SecA molecule and preprotein (41) while shielding SecA from
contact with the phospholipids phase (42, 43). Our studies do
not support such large helical rearrangements, as both TMS2
and TMS7 of SecY remain in close proximity to TMS3 of SecE
during translocation. Rather, our studies indicate the recruit-
ment of multiple SecYEG complexes much akin to a “rigid
body” assembly event. To further test this model, future bio-
chemical experiments should be directed at the mapping of the
intramolecular contacts between the helices within the SecY
protein.
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